glp 1 agonist and dpp 4 inhibitor dpp-4_inhibitors [TUSOM Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)
Description
Introduction Obesity poses a significant burden to individual and public health [1]
Each insight affects clinical workflows, risk profiles, and tech architecture
This allows the active compound to be absorbed into the bloodstream with near-perfect efficiency
What this article covers: What Are GLP-1 Drugs
Winners will pair low price with fast regulatory clearance, device equivalence, and contracted access
doi: 10.1111/j.1742-481X.2012.01022.x [DOI] [PMC free article] [PubMed] [Google Scholar] 182
